Kevis Announces the Release of Latest Hair Treatment Kevis 8

Share Article

New Kevis product uses powerful yet safe ingredients to prevent and reverse hair thinning or loss.

Past News Releases


Kevis, the online retailer for hair rejuvenation treatments and programs, is excited to introduce Kevis 8, the 8th generation of Kevis hair loss treatments.

Formed in the 1990s, Kevis has been continually improving its hair loss treatments through the observations and research of an Italian doctor and scientist who developed the original Kevis product. The newest Kevis 8 formula combines two ingredients that are medically proven to target hair loss at the root of the problem: the hair follicle. These ingredients are mixed and applied to the scalp, creating a potent hair loss treatment and delivering the best results possible.

The medically recognized cause of hair loss DHT, or di-hydro-testosterone. What makes Kevis 8 so effective is the unique blend of ingredients, pharmaceutical grade hyaluronic acid and Tricozyme. The prescription strength hyaluronic acid works to break down the accumulated DHT, while Tricozyme is a protein enzyme that attaches itself to the released DHT and renders it inactive. Kevis 8 also contains powerful hair nutrients and all-natural vasodialtion elements, which facilitate blood flow, to insure a topical procedure that is safe and effective. Because Kevis 8 is distilled water-based, it is very easy to apply.

Kevis products contain no drugs and require no medical supervision, and its shampoos, conditioners, and lotions contain no harmful chemicals. There are no side effects from applying these easy-to-use products, and Kevis provides safe and effective treatments for both men and women of all ages. Kevis’ patented solution has undergone successful clinical testing and has received United States and European patents. Kevis hair products have been available in the United States for over 10 years and in European dermatological and pharmaceutical professional.

Call: 1-866-944-1799

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Derrick Fuller

Email >